All Stories

  1. Study Comparing Traditional Versus Alternative Metrics to Measure the Impact of the Critical Care Medicine Literature

    Article • Critical Care Explorations, August 2019, Wolters Kluwer Health

    Dr Benjamin P Geisler

  2. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes

    Article • Journal of Hospital Infection, August 2019, Elsevier

    Dr Benjamin P Geisler

  3. Utilizing a PLASMIC score‐based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative

    Article • British Journal of Haematology, May 2019, Wiley

    Dr Benjamin P Geisler

  4. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting

    Article • Respiration, January 2019, Karger Publishers

    Dr Benjamin P Geisler

  5. Adoption Patterns of Bronchoscopic Lung Volume Reduction Procedures in Germany and Predicted Procedure Volumes for Other European Countries

    Article • Respiration, August 2018, Karger Publishers

    Dr Benjamin P Geisler

  6. Should Surgical Repair Be Recommended Over Nonoperative Management for Medial Meniscus Root Tears? Response

    Article • The American Journal of Sports Medicine, July 2018, SAGE Publications

    Dr Benjamin P Geisler, Dr. Robert F. LaPrade

  7. Meniscus Root Repair vs Meniscectomy or Nonoperative Management to Prevent Knee Osteoarthritis After Medial Meniscus Root Tears: Clinical and Economic Effectiveness

    Article • The American Journal of Sports Medicine, March 2018, SAGE Publications

    Dr Benjamin P Geisler, Dr. Robert F. LaPrade

  8. Outcomes of Ventilated Patients With Sepsis Who Undergo Interhospital Transfer

    Article • Critical Care Medicine, January 2018, Wolters Kluwer Health

    Dr Benjamin P Geisler

  9. Racial and Geographic Disparities in Interhospital ICU Transfers*

    Article • Critical Care Medicine, January 2018, Wolters Kluwer Health

    Dr Benjamin P Geisler

  10. Correction to: Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan

    Article • Cardiovascular Intervention and Therapeutics, October 2017, Springer Science + Business Media

    Dr Benjamin P Geisler

  11. Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial

    Article • Structural Heart, September 2017, Taylor & Francis

    Dr Benjamin P Geisler

  12. Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan

    Article • Cardiovascular Intervention and Therapeutics, September 2017, Springer Science + Business Media

    Dr Benjamin P Geisler

  13. Response to Lee et al.

    Article • Journal of Thoracic Oncology, September 2017, Elsevier

    Dr Benjamin P Geisler

  14. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer

    Article • Journal of Thoracic Oncology, August 2017, Elsevier

    Dr Benjamin P Geisler

  15. Value in Oral and Maxillofacial Surgery: A Systematic Review of Economic Analyses

    Article • Journal of Oral and Maxillofacial Surgery, May 2017, Elsevier

    Dr Benjamin P Geisler

  16. Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria

    Article • Value in Health, November 2016, Elsevier

    Dr Benjamin P Geisler

  17. Dyspnea and Chest Pain in a Young Woman Caused by a Giant Pericardial Lymphohemangioma: Diagnosis and Treatment

    Article • Canadian Journal of Cardiology, October 2016, Elsevier

    Dr Benjamin P Geisler

  18. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK

    Article • BMJ Open, May 2016, BMJ

    Dr Benjamin P Geisler

  19. COST EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION VERSUS SURGICAL AORTIC VALVE REPLACEMENT: THE COREVALVE HIGH RISK TRIAL FROM A DUTCH PERSPECTIVE

    Article • Value in Health, May 2016, Elsevier

    Dr Benjamin P Geisler

  20. Economic Analysis of Drug-Coated Balloons And Other Endovascular Treatments For Femoropopliteal Artery Disease In The United Kingdom

    Article • Value in Health, May 2016, Elsevier

    Dr Benjamin P Geisler

  21. Cardiovascular Benefits of the Mediterranean Diet Are Driven by Stroke Reduction and Possibly by Decreased Atrial Fibrillation Incidence

    Article • The American Journal of Medicine, January 2016, Elsevier

    Dr Benjamin P Geisler

  22. Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease: Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence

    Article • Value in Health, November 2015, Elsevier

    Dr Benjamin P Geisler

  23. Cost-Effectiveness of Transcatheter Aortic Valve Replacement: Current Decision-Analytic Models and Future Opportunities

    Article • Value in Health, November 2015, Elsevier

    Dr Benjamin P Geisler

  24. Adoption Of Transcatheter Aortic Valve Replacement In Germany: Utilization Patterns And Case Volumes Compared To Surgical Aortic Valve Replacement In The Period 2009-2013

    Article • Value in Health, November 2015, Elsevier

    Dr Benjamin P Geisler

  25. TCT-157 The Impact of transcatheter aortic valve replacement on therapy utilization and case volumes in Germany, 2009-2013

    Article • Journal of the American College of Cardiology, October 2015, Elsevier

    Dr Benjamin P Geisler

  26. COMPARATIVE SAFETY OF INTRAVENOUS NICARDIPINE INFUSION IN PATIENTS WITH AND WITHOUT SYSTOLIC DYSFUNCTION

    Article • Journal of the American College of Cardiology, March 2015, Elsevier

    Dr Benjamin P Geisler

  27. Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome

    Article • Journal for ImmunoTherapy of Cancer, February 2015, Springer Science + Business Media

    Dr Benjamin P Geisler

  28. Do Insurers Compete on the Federal Health Insurance Exchange?

    Article • F1000Research, January 2015, Faculty of 1000, Ltd.

    Dr Benjamin P Geisler

  29. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study

    Article • Clinical Research in Cardiology, November 2014, Springer Science + Business Media

    Dr Benjamin P Geisler

  30. Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension: Impact Of Age And Cardiovascular Risk Factors

    Article • Value in Health, November 2014, Elsevier

    Dr Benjamin P Geisler

  31. Gabapentin Treatment for Alcohol Dependence

    Article • JAMA Internal Medicine, July 2014, American Medical Association (AMA)

    Dr Benjamin P Geisler

  32. Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany

    Article • Catheterization and Cardiovascular Interventions, May 2014, Wiley

    Dr Benjamin P Geisler

  33. GIANT CARDIAC LYMPHANGIOMA WITH COMPLETE ENCASEMENT OF THE RIGHT CORONARY ARTERY: IMAGING AND THERAPEUTIC APPROACH

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Benjamin P Geisler

  34. Correction

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Dr Benjamin P Geisler

  35. Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico

    Article • Value in Health, November 2013, Elsevier

    Dr Benjamin P Geisler

  36. Cost-effectiveness of catheter-based renal denervation for resistant hypertension – a canadian perspective

    Article • Value in Health, May 2013, Elsevier

    Dr Benjamin P Geisler

  37. PMD20 Budget Impact of Drug Eluting Balloons for Intermittent Claudication From Superficial Femoral Artery Disease in the United States Health Care System

    Article • Value in Health, November 2012, Elsevier

    Dr Benjamin P Geisler

  38. PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 Trial

    Article • Value in Health, November 2012, Elsevier

    Dr Benjamin P Geisler

  39. Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension

    Article • Journal of the American College of Cardiology, October 2012, Elsevier

    Dr Benjamin P Geisler

  40. PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes: The Case of Renal Denervation for Resistant Hypertension

    Article • Value in Health, June 2012, Elsevier

    Dr Benjamin P Geisler

  41. EFFICACY AND CLINICAL AND ECONOMIC EFFECTIVENESS IN RESISTANT HYPERTENSIVE SUBGROUPS

    Article • Journal of the American College of Cardiology, March 2012, Elsevier

    Dr Benjamin P Geisler

  42. Trauma and Burn Education: A Global Survey

    Article • World Journal of Surgery, January 2012, Springer Science + Business Media

    Dr Benjamin P Geisler

  43. Correction: Use of Observation Care in US Emergency Departments, 2001 to 2008

    Article • PLoS ONE, January 2012, PLOS

    Dr Benjamin P Geisler

  44. Determining Health-Related Quality of Life and Health State Utility Values of Urinary Incontinence in Women

    Article • Female Pelvic Medicine & Reconstructive Surgery, November 2011, Wolters Kluwer Health

    Dr Benjamin P Geisler

  45. Use of Observation Care in US Emergency Departments, 2001 to 2008

    Article • PLoS ONE, September 2011, PLOS

    Dr Benjamin P Geisler

  46. Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure

    Article • PharmacoEconomics, September 2011, Springer Science + Business Media

    Dr Benjamin P Geisler

  47. Perspectives on “Early Dialogue” between a Manufacturer and Health Technology Assessment Agencies

    Article • Value in Health, June 2011, Elsevier

    Dr Benjamin P Geisler

  48. Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents

    Article • Expert Opinion on Biological Therapy, July 2010, Informa Healthcare

    Dr Benjamin P Geisler

  49. Leadership in health care

    Article • Journal of Health Organization and Management, June 2010, Emerald

    Dr Benjamin P Geisler

  50. Health State Survey-Derived Utilities in Cost-Utility Analysis—A Call to Action

    Article • Value in Health, March 2010, Elsevier

    Dr Benjamin P Geisler

  51. Estimates of Electronic Medical Records in U.S. Emergency Departments

    Article • PLoS ONE, February 2010, PLOS

    Dr Benjamin P Geisler

  52. Gesundheitsökonomische Evaluation der INH (interdisziplinäres Netzwerk Herzinsuffizienz)-Studie

    Article • Das Gesundheitswesen, August 2009, Thieme Publishing Group

    Dr Benjamin P Geisler

  53. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure

    Article • Heart, July 2009, BMJ

    Dr Benjamin P Geisler

  54. Additional Factors That Could Improve Cost-Effectiveness of Pharmacogenetic-Guided Dosing in Warfarin Therapy

    Article • Annals of Internal Medicine, July 2009, American College of Physicians

    Dr Benjamin P Geisler

  55. PHP9 THE IMPACT OF LEGISLATION AND PRICING ON GENERIC DRUG UTILIZATION: AN ANALYSIS OF 26 COUNTRIES

    Article • Value in Health, May 2009, Elsevier

    Dr Benjamin P Geisler

  56. Deterministic Sensitivity Analysis for First-Order Monte Carlo Simulations: A Technical Note

    Article • Value in Health, January 2009, Elsevier

    Dr Benjamin P Geisler

  57. Utility Estimates for Decision–Analytic Modeling in Chronic Heart Failure—Health States Based on New York Heart Association Classes and Number of Rehospitalizations

    Article • Value in Health, January 2009, Elsevier

    Dr Benjamin P Geisler

  58. Decision‐analytic evaluation of the clinical effectiveness and cost‐effectiveness of management programmes in chronic heart failure

    Article • European Journal of Heart Failure, October 2008, Wiley

    Dr Benjamin P Geisler